Heinz Schwer

Heinz is a successful entrepreneur in biotech industry. He currently serves EMBL Ventures as General Partner focusing on venture building in life science. Prior to that, Heinz was CEO of various biotech companies in Austria, The Netherlands and Germany of which all were acquired by large pharma or biotech companies. Heinz studied Chemistry in Regensburg and earned his PhD in Clinical Chemistry. He was postdoc at Harvard Medical School, USA and holds an MBA from Henley Business School, UK.